Literature DB >> 21535311

Distribution of human papillomavirus type 16 E6 and E7 gene variants in the progression of cervical dysplasia in Korean women.

Chung-Won Lee1, Jeong-Hoon Bae, Sung-Jong Lee, Eun-Mi Ho, Il-Han Lee, Yong-Gyu Park, Jong-Sup Park.   

Abstract

AIM: This cross-sectional, hospital-based study examined the distribution of human papillomavirus 16 E6 and E7 gene variants in Korean women with cervical lesions of varying degrees. MATERIAL &
METHODS: One hundred and forty-one Korean women (median age 43 years; range 22-65 years) with human papillomavirus 16 single infections were included. The human papillomavirus 16 E6/E7 sequences were amplified from cytology specimens. The distribution of human papillomavirus 16 variations with respect to cervical lesion was examined by the exact Mantel-Haenszel linear trend test (P(trend) ) and Fisher's exact test (P).
RESULTS: Human papillomavirus 16 E6 and E7 gene variants were identified in a total of 100 women (70.9%). The most prevalent human papillomavirus 16 variants were E6 Thymine178Guanine (number = 70, 49.6%) and E7 Adenine647Guanine (number = 75, 53.2%). Human papillomavirus 16 E6 Thymine178Guanine and E7 Adenine647Guanine were significantly related to the degree of cervical neoplasia (P(trend) = 0.0002, P< 0.0001; P(trend) < 0.0001, P < 0.0001, respectively). The odds ratio of human papillomavirus 16 E6 Thymine178Guanine to predict progression to cervical intraepithelial neoplasia 2-3 and invasive cancer was 2.37 (95% confidence interval 1.03-5.45) and 9.07 (95% confidence interval 2.86-28.72), respectively. The odds ratio of E7 Adenine647Guanine to predict progression to cervical intraepithelial neoplasia 2-3 and invasive cancer was 3.65 (95% confidence interval 1.16-8.51) and 9.07 (95% confidence interval 2.86-28.72), respectively.
CONCLUSION: The distribution of HPV variants appears to be related to geographic difference. Human papillomavirus 16 E6 Thymine178Guanine and E7 Adenine647Guanine can be used as the candidate marker for the progression of the cervical neoplasia.
© 2011 The Authors. Journal of Obstetrics and Gynaecology Research © 2011 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535311     DOI: 10.1111/j.1447-0756.2010.01520.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Association of HLA-DRB1, HLA-DQB1 Polymorphisms with HPV 16 E6 Variants among Young Cervical Cancer Patients in China.

Authors:  Yan Hu; Jin-Ze Wu; Hua Zhu; Sheng-Hui Zhang; Yan-Ying Zhu; Yi-Yao Wu; Ci-Xia Shuai
Journal:  J Cancer       Date:  2017-07-22       Impact factor: 4.207

2.  Association of Human Papillomavirus Type 16 Long Control Region Variations with Cervical Cancer in a Han Chinese Population.

Authors:  Shuying Dai; Chuanyin Li; Zhiling Yan; Ziyun Zhou; Xia Wang; Jun Wang; Le Sun; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2020-03-26       Impact factor: 3.738

3.  E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico.

Authors:  Ramón Antaño-Arias; Oscar Del Moral-Hernández; Julio Ortiz-Ortiz; Luz Del Carmen Alarcón-Romero; Jorge Adán Navor-Hernández; Marco Antonio Leyva-Vázquez; Marco Antonio Jiménez-López; Jorge Organista-Nava; Berenice Illades-Aguiar
Journal:  Pathogens       Date:  2021-06-20

Review 4.  Metabolic Reprogramming in Cancer: Role of HPV 16 Variants.

Authors:  Adán Arizmendi-Izazaga; Napoleón Navarro-Tito; Hilda Jiménez-Wences; Miguel A Mendoza-Catalán; Dinorah N Martínez-Carrillo; Ana E Zacapala-Gómez; Monserrat Olea-Flores; Roberto Dircio-Maldonado; Francisco I Torres-Rojas; Diana G Soto-Flores; Berenice Illades-Aguiar; Julio Ortiz-Ortiz
Journal:  Pathogens       Date:  2021-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.